Upstate Active Clinical Trials

Study Title:

CALGB 90601: A Randomized Double-Blinded Phase III Study Comparing Gemcitabine, Cisplatin, and Bevacizumab (IND #7921, NSC #704865) to Gemcitabine, Cislpatin, and Placebo in Patients with Advanced Transitional Cell Carcinoma

What is the purpose of the study?

The purpose of this study is to compare the effects of the combination of the chemotherapy drugs gemcitabine and cisplatin (chemotherapy) with the combination of gemcitabine, cisplatin and the experimental drug bevacizumab on transitional cell cancer.

Upstate Institutional Review Board (IRB) Number:

235816

Study Phase:

III

Patient Age Group:

Adults

Principal Investigator:

Bernard J Poiesz, MD

ClinicalTrials.Gov ID:

NCT00942331

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Diane M Gould
Phone: 315-464-8235
Email: gouldd@upstate.edu

Return to Previous Page || Search Again